LEADER 03006nam  22006734a 450 
001 9910453729303321
005 20200520144314.0
010   $a1-281-82598-0
010   $a9786611825980
010   $a0-19-970933-5
035   $a(CKB)1000000000553679
035   $a(EBL)415113
035   $a(OCoLC)476240107
035   $a(SSID)ssj0000109718
035   $a(PQKBManifestationID)11142810
035   $a(PQKBTitleCode)TC0000109718
035   $a(PQKBWorkID)10059561
035   $a(PQKB)10487269
035   $a(MiAaPQ)EBC415113
035   $a(Au-PeEL)EBL415113
035   $a(CaPaEBR)ebr10254460
035   $a(CaONFJC)MIL182598
035   $a(EXLCZ)991000000000553679
100   $a20080220d2009      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aBefore Prozac$b[electronic resource] $ethe troubled history of mood disorders in psychiatry /$fEdward Shorter
210   $aOxford ;$aNew York $cOxford University Press$d2009
215   $a1 online resource (321 p.)
300   $aDescription based upon print version of record.
311   $a0-19-536874-6 
320   $aIncludes bibliographical references and index.
327   $aBefore psychopharmacology -- The first drug set -- Power play -- Killer drugs! -- Death sentences -- "The plague of affective disorders" -- Losing ground -- What now?
330   $aPsychiatry today is a barren tundra, writes medical historian Edward Shorter, where drugs that don't work are used to treat diseases that don't exist. In this provocative volume, Shorter illuminates this dismal landscape, in a revealing account of why psychiatry is ""losing ground"" in the struggle to treat depression. Naturally, the book looks at such culprits as the pharmaceutical industry, which is not inclined to market drugs once the patent expires, leading to the endless introduction of new--but not necessarily better--drugs. But the heart of the book focuses on an unexpected villain: th
606   $aAffective disorders$xChemotherapy$zUnited States$xHistory
606   $aPsychotropic drugs$zUnited States$xHistory
606   $aPsychopharmacology$zUnited States$xHistory
606   $aSerotonin uptake inhibitors$xTherapeutic use$xHistory
606   $aPsychotropic drugs industry$zUnited States$xHistory
606   $aPharmaceutical policy$zUnited States$xHistory
608   $aElectronic books.
615  0$aAffective disorders$xChemotherapy$xHistory.
615  0$aPsychotropic drugs$xHistory.
615  0$aPsychopharmacology$xHistory.
615  0$aSerotonin uptake inhibitors$xTherapeutic use$xHistory.
615  0$aPsychotropic drugs industry$xHistory.
615  0$aPharmaceutical policy$xHistory.
676   $a616.85/27061
700   $aShorter$b Edward$0128248
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910453729303321
996   $aBefore Prozac$91924321
997   $aUNINA

LEADER 01363nam0 22002771i 450 
001 UON00043790
005 20231205102157.420
100   $a20020107f1900       |0itac50      ba
101   $ager
102   $aDE
105   $a||||    1||||
200 1 $aLehrbuch der Neusyrischen schrift und umgangssprache$egrammatik, konversation, korrespondenz und chrestomathie$fvon I. Rosenberg
210   $aWien$cA. Hartleben's$d[1900]
215   $aVIII, 159 p.$d18 cm
410  1$1001UON00066420$12001 $aˆDie ‰Kunst der Polyglottie$eEine auf Erfahrung begrundete Anleitung, jede Sprache in kurzefter Zeit in bezug auf Veritandnis, Konversation und Schriftsprache durch Selbstunterricht sich anzueignen$v77
606   $aLINGUA SIRIACA$xGrammatica$3UONC005728$2FI
620   $aAT$dWien$3UONL003140
686   $aSIPA II SR B$cSIRIA E PALESTINA - LINGUISTICA - SIRIACO - GRAMMATICHE$2A
700  1$aROSENBERG$bI.$3UONV027757$0648859
712   $aHartleben, Conrad A.$3UONV251181$4650
801   $aIT$bSOL$c20240220$gRICA
899   $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$2UONSI
912   $aUON00043790
950   $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI SIPA      II SR                   B           006                 $eSI MR 22918    7        006                 
996   $aLehrbuch der Neusyrischen schrift und umgangssprache$91157646
997   $aUNIOR